Bayer is discontinuing its Calantic Digital Solutions AI platform and ceasing Blackford Analysis services, signaling a major retreat from the radiology AI platform sector.
Key Details
- 1Bayer will exit the radiology AI software platform business, discontinuing Calantic and Blackford Analysis offerings.
- 2Calantic was launched in 2022 and built on Blackford's platform, which Bayer fully acquired in 2023.
- 3Blackford's platform currently hosts over 150 third-party AI apps from more than 60 developers across multiple clinical domains.
- 4A dedicated Bayer team will handle the transition, honoring existing contracts; future sale plans for Blackford are not confirmed.
- 5Industry experts suggest the move may trigger a consolidation wave in the radiology AI platform market and signal underlying adoption and integration challenges.
Why It Matters
Bayer’s withdrawal removes a key player and nearly 10% of spending from the global radiology AI platform ecosystem, raising concerns about the long-term viability of the platform model and potentially slowing broader AI adoption in radiology due to market uncertainty and loss of confidence.
Source
AuntMinnie
Related News
•Radiology Business
Cigna Expands Nationwide Coverage for CT Imaging AI Tools
Cigna will reimburse for CT-based plaque analysis AI software for millions of members nationwide.
•Health Imaging
St. Luke's Network Deploys AI Radiology Tool Systemwide
St. Luke’s University Health Network has implemented Gleamer’s BoneView AI tool for bone abnormality detection across all its locations.
•Radiology Business
ACR Expands Support for Safe AI Integration in Radiology
The ACR is intensifying programs to help radiology practices safely and effectively adopt artificial intelligence.